We are live on ! Find out more
AC

Antara Capital Portfolio holdings

AUM $30.2K
1-Year Est. Return 5.24%
This Fund
S&P 500
This Quarter Est. Return
-11.07%
1 Year Est. Return
-5.24%
3 Year Est. Return
-39.78%
5 Year Est. Return
-45.29%
10 Year Est. Return
AUM
$1.12B
AUM Growth
-$1.92B
Cap. Flow
-$1.91B
Cap. Flow %
-170.25%
Top 10 Hldgs %
90.24%
Holding
82
New
10
Increased
8
Reduced
7
Closed
27
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBL
26
CBL Properties
CBL
$1.86B
$168K 0.02%
8,017
-244,559
-97% -$5.32M
OABIW icon
27
OmniAb Inc Warrant
OABIW
$10.2M
$165K 0.01%
148,499
PEGRW
28
DELISTED
Project Energy Reimagined Acquisition Corp. Warrant
PEGRW
$149K 0.01%
1,237,500
RBT
29
DELISTED
Rubicon Technologies, Inc.
RBT
$94.5K 0.01%
45,455
THCH icon
30
TH International
THCH
$52.5M
$43.4K ﹤0.01%
4,800
XAGEW
31
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$43.2K ﹤0.01%
196,250
INVZ icon
32
CALL
Innoviz Technologies
INVZ
$99.5M
$29.3K ﹤0.01%
15,000
-3,285,000
-100% -$8.83M
KRNLW
33
DELISTED
Kernel Group Holdings, Inc. Warrants
KRNLW
$26.9K ﹤0.01%
452,224
MPRAW
34
DELISTED
Mercato Partners Acquisition Corporation Warrant
MPRAW
$25.9K ﹤0.01%
123,400
MCAAW
35
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
$24K ﹤0.01%
150,000
MSPRZ
36
DELISTED
MSP Recovery Inc Warrant
MSPRZ
$20.7K ﹤0.01%
85,500
ACAQ.WS
37
DELISTED
Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share
ACAQ.WS
$18K ﹤0.01%
50,000
RBT.WS
38
DELISTED
Rubicon Technologies, Inc. Warrants, each warrant is exercisable for 1/8th of a share of Class A Common Stock at an exercise price of $92.00r share
RBT.WS
$14.2K ﹤0.01%
1,263,636
LDTCW
39
DELISTED
LeddarTech Holdings Inc. Warrants
LDTCW
$12.4K ﹤0.01%
190,500
OPA.WS
40
DELISTED
Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
OPA.WS
$9.85K ﹤0.01%
250,000
CCGWW
41
Cheche Group Inc Warrant
CCGWW
$256K
$8.57K ﹤0.01%
+41,000
New +$12.7K
HWELW
42
DELISTED
Healthwell Acquisition Corp. I Warrant
HWELW
$7.18K ﹤0.01%
42,265
ECXWW
43
ECARX Holdings Warrants
ECXWW
$6.61K ﹤0.01%
165,330
BLUA
44
DELISTED
BlueRiver Acquisition Corp.
BLUA
$6.44K ﹤0.01%
+133,333
New +$1.41M
TGAAW
45
DELISTED
Target Global Acquisition I Corp. Warrant
TGAAW
$5.74K ﹤0.01%
99,933
APGB.WS
46
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$4.16K ﹤0.01%
53,000
HLGN.WS
47
DELISTED
Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
HLGN.WS
$3.79K ﹤0.01%
102,711
ROCLW
48
DELISTED
Roth CH Acquisition V Co. Warrant
ROCLW
$3K ﹤0.01%
37,500
JAQCW
49
DELISTED
Jupiter Acquisition Corporation Warrants
JAQCW
$3K ﹤0.01%
75,000
BSLKW
50
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$2.17K ﹤0.01%
60,000

Similar funds

Antara Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Antara Capital held 82 positions worth $1.12B, down 63% from $3.04B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Antara Capital withdrew a net $1.91B in Q3 2023, closing 27 positions and reducing 7 holdings. Its most notable exit was Aurinia Pharmaceuticals, an estimated $4.89M position sold in full.

By sector, the portfolio is most concentrated in Financials at 2.3% of assets, up from 0.5% a quarter earlier, followed by Consumer Discretionary and Utilities.

Against the trend, Antara Capital opened a new position in Hennessy Capital Investment Corp. VI Class A Common Stock worth $10.9M.

  • Antara Capital's largest Q3 2023 buy was Hennessy Capital Investment Corp. VI Class A Common Stock: 1,050,000 shares worth $10.9M.
  • Antara Capital added most to ChargePoint in Q3 2023, an estimated $6.54M increase.
  • Antara Capital's biggest Q3 2023 reduction was Innoviz Technologies, cutting an estimated $10.4M.
  • Antara Capital fully exited Aurinia Pharmaceuticals in Q3 2023, selling an estimated $4.89M.
  • Antara Capital's ten largest holdings make up 90% of its $1.12B portfolio in Q3 2023.
  • Antara Capital opened 10 new positions and closed 27 in Q3 2023.
  • Antara Capital's portfolio value fell 63% quarter-over-quarter to $1.12B.

Based on Antara Capital's 13F filing for Q3 2023, filed 14 Nov 2023.